Projects per year
Personal profile
Research interests
Uro-oncology (bladder and prostate)
specialisation
Urology
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
de Reijke T.M.: [NO DATA]
Bus, M., Liem, E., Muller, B., Smeenge, M., van der Toom, E. & de Reijke, T.
31/05/2010 → …
Project: Research
-
de la Rosette J.J.M.C.H.: Minimal Invasive Urology and Oncological Urology
Baard, J., Buijs, M., Bus, M., Freund, J. E., Jansen, I., Legemate, J., Liem, E., Mannaerts, C., Muller, B., Postema, A., Sandbergen, L., Scheltema, M., Smeenge, M., van der Toom, E., Zondervan, P., Delarosette, J., Gerbrandy - Schreuders, L., Joosten, E., Kamphuis, G., Laguna Pes, M., Meißner, A., de Reijke, T., Wijkstra, H., Zondervan, P., de Bruin, M., Idzenga, T., Maas, I. & Wijdenes, M.
1/01/2006 → 13/06/2016
Project: Research
-
Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder
Sylvester, R. J., Brausi, M. A., Kirkels, W. J., Hoeltl, W., Calais Da Silva, F., Powell, P. H., Prescott, S., Kirkali, Z., van de Beek, C., Gorlia, T. & de Reijke, T. M., 2010, In: European Urology. 57, 5, p. 766-773Research output: Contribution to journal › Article › Academic › peer-review
327 Citations (Scopus) -
Duration of androgen suppression in the treatment of prostate cancer
AUTHOR GROUP, 2009, In: New England journal of medicine. 360, 24, p. 2516-2527Research output: Contribution to journal › Article › Academic › peer-review
806 Citations (Scopus) -
Propagation of Human Spermatogonial Stem Cells In Vitro
Sadri-Ardekani, H., Mizrak, S. C., van Daalen, S. K. M., Korver, C. M., Roepers-Gajadien, H. L., Koruji, M., Hovingh, S., de Reijke, T. M., de La Rosette, J. J. M. C. H., van der Veen, F., de Rooij, D. G., Repping, S. & van Pelt, A. M. M., 2009, In: JAMA. 302, 19, p. 2127-2134Research output: Contribution to journal › Article › Academic › peer-review
308 Citations (Scopus) -
Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follow-up
Studer, U. E., Whelan, P., Wimpissinger, F., Casselman, J., de Reijke, T. M., Knönagel, H., Loidl, W., Isorna, S., Sundaram, S. K. & Collette, L., 2014, In: European Urology. 66, 5, p. 829-838Research output: Contribution to journal › Article › Academic › peer-review
56 Citations (Scopus) -
Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer
Leyten, G. H. J. M., Hessels, D., Jannink, S. A., Smit, F. P., de Jong, H., Cornel, E. B., de Reijke, T. M., Vergunst, H., Kil, P., Knipscheer, B. C., van Oort, I. M., Mulders, P. F. A., Hulsbergen-van de Kaa, C. A. & Schalken, J. A., 2014, In: European Urology. 65, 3, p. 534-542Research output: Contribution to journal › Article › Academic › peer-review
296 Citations (Scopus)